Table 2.
R2′ (mean±SD) measured in different regions of the brain after each dose of Molday or Feraheme. See also Figure 2.
| dose | R2′ in S1FL (s−1) | R2′ in cc (s−1) | R2′ in M1 (s−1) | R2′ in Str (s−1) | R2′ in S2 (s−1) | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Molday | Feraheme | Molday | Feraheme | Molday | Feraheme | Molday | Feraheme | Molday | Feraheme | |
| 1st dose | 39.7±5.3 | 22.1±5.4 | 44.4±5.7 | 17.9±3.8 | 42.7±8.2 | 17.1±2.6 | 57.8±15.0 | 29.8±6.4 | 47.1±7.2 | 20.4±4.6 |
| 2nd dose | 58.9±7.7 | 34.3±8.6 | 58.5±8.1 | 25.9±4.3 | 65.7±14.0 | 29.0±5.4 | 77.0±11.9 | 45.3±9.2 | 70.1±15.6 | 34.5±8.0 |
| 3rd dose | 87.3±14.4 | 44.3±9.2 | 79.7±10.5 | 31.8±3.8 | 99.9±28.8 | 38.8±7.7 | 119.6±22.1 | 59.0±12.0 | 109.5±19.8 | 46.8±7.8 |